APTV vs CNTA · P/E 41, rev $19.71B vs $6.15B cap
Aptiv PLC (APTV) versus Centessa Pharmaceuticals PLC ADR (CNTA) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. CNTA currently screens at market cap $6.15B.
Not investment advice. Open the APTV and CNTA stock pages for the full models.
Not investment advice.